Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04815005 · ClinicalTrials.gov registry record
HoFH, the International Clinical Collaborators Registry
A clinical trial of Homozygous Familial Hypercholesterolemia, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 4
- Study locations
NCT04815005: Recruiting study of Homozygous Familial Hypercholesterolemia, sponsored by University of Pennsylvania.
NCT04815005 is a study of Homozygous Familial Hypercholesterolemia that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,000 participants, above the 86-participant average among 6 other Homozygous Familial Hypercholesterolemia trials with a reported enrollment target (1063% higher). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04815005, a study of Homozygous Familial Hypercholesterolemia, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
Homozygous familial hypercholesterolemia (HoFH), a rare inherited disorder caused by bi-allelic mutations in the LDL Receptor pathway, is characterized by extremely elevated levels of low-density lipoprotein cholesterol (LDL-C) from birth and premature atherosclerotic cardiovascular disease (ASCVD). Our current knowledge about HoFH is disjointed and largely stems from relatively small case series and expert opinion. HICC (Homozygous FH International Clinical Collaborators) is a global consortium of clinicians who are contributing de-identified data of patients diagnosed with HoFH with the goal to advance our understanding of this rare disease.
Primary Outcome
Number of study participants with homozygous familial hypercholesterolemia
Conditions Studied
Interventions
- OTHER Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence.
Study Locations (4)
Other
- Department of Vascular Medicine, Amsterdam UMC - Amsterdam
- Department of Medicine, Division of Lipidology and Hatter Institute for Cardiovascular Research in Africa, University of Cape Town - Cape Town
- c. Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand - Johannesburg
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-01-24 |
| Est. Completion | 2026-12-31 |
What NCT04815005 shows while recruiting
NCT04815005 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 86-participant average among 6 other Homozygous Familial Hypercholesterolemia trials with a reported enrollment target (1063% higher).
The record links to 1 condition, with Homozygous Familial Hypercholesterolemia appearing as the primary indexed condition, and to 1 intervention - of which Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence. is the first listed.
NCT04815005 reports a single indexed study location in Other, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04815005 about?
NCT04815005 is a clinical study titled "HoFH, the International Clinical Collaborators Registry". Homozygous familial hypercholesterolemia (HoFH), a rare inherited disorder caused by bi-allelic mutations in the LDL Receptor pathway, is characterized by extremely elevated levels of low-density lipoprotein cholesterol (LDL-C) from birth and premature atherosclerotic cardiovascular disease (ASCVD)....
What is the current status of trial NCT04815005?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2017-01-24. Estimated completion is 2026-12-31.
What conditions does trial NCT04815005 study?
This clinical trial studies the following conditions: Homozygous Familial Hypercholesterolemia.
What interventions are being tested in trial NCT04815005?
The interventions under investigation include: Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence. (OTHER).
Who is sponsoring clinical trial NCT04815005?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04815005 being conducted?
This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Homozygous Familial Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
RECRUITING
-
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
RECRUITING · Phase 3
-
LOWER: Lomitapide Observational Worldwide Evaluation Registry
RECRUITING
-
Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)
ACTIVE NOT RECRUITING · Phase 2
-
Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor
COMPLETED · Phase 2
-
Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI